Asset Dedication LLC Buys 454 Shares of UnitedHealth Group Incorporated (UNH)
Asset Dedication LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,528 shares of the healthcare conglomerate’s stock after buying an additional 454 shares during the quarter. Asset Dedication LLC’s holdings in UnitedHealth Group were worth $1,678,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Balasa Dinverno & Foltz LLC increased its position in UnitedHealth Group by 6.0% in the 3rd quarter. Balasa Dinverno & Foltz LLC now owns 9,324 shares of the healthcare conglomerate’s stock valued at $1,826,000 after buying an additional 531 shares in the last quarter. Culbertson A N & Co. Inc. bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $258,000. Howe & Rusling Inc. increased its position in UnitedHealth Group by 8,795.9% in the 3rd quarter. Howe & Rusling Inc. now owns 25,798 shares of the healthcare conglomerate’s stock valued at $5,053,000 after buying an additional 25,508 shares in the last quarter. Mutual of America Capital Management LLC increased its position in UnitedHealth Group by 4.9% in the 3rd quarter. Mutual of America Capital Management LLC now owns 147,715 shares of the healthcare conglomerate’s stock valued at $28,930,000 after buying an additional 6,873 shares in the last quarter. Finally, Moloney Securities Asset Management LLC increased its position in UnitedHealth Group by 10.9% in the 3rd quarter. Moloney Securities Asset Management LLC now owns 8,243 shares of the healthcare conglomerate’s stock valued at $1,614,000 after buying an additional 809 shares in the last quarter. 86.20% of the stock is currently owned by hedge funds and other institutional investors.
UNH has been the subject of a number of research analyst reports. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Cantor Fitzgerald boosted their price objective on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Credit Suisse Group assumed coverage on UnitedHealth Group in a report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price objective for the company. Wells Fargo & Company restated an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, UBS restated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $224.56.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the business posted $2.17 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is 33.26%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 12,032 shares of company stock valued at $2,658,310 in the last ninety days. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.